EVP & CFO
EVP & CFO at Royalty Pharma plc, filing insider transactions between 2025-11-17 and 2026-05-26.
| SEC ↗ |
| 2026-04-01 | RPRX | Sale | 32.9K | $48.33 | $1.6M | SEC ↗ |
| 2026-04-01 | RPRX | Sale | 1,875 | $48.33 | $91K | SEC ↗ |
| 2026-03-23 | RPRX | Sale | 1,875 | $45.53 | $85K | SEC ↗ |
| 2026-03-23 | RPRX | Sale | 32.9K | $45.53 | $1.5M | SEC ↗ |
| 2026-03-02 | RPRX | Sale | 1,292 | $46.67 | $60K | SEC ↗ |
| 2026-03-02 | RPRX | Sale | 583 | $47.01 | $27K | SEC ↗ |
| 2026-03-02 | RPRX | Sale | 22.5K | $46.67 | $1.0M | SEC ↗ |
| 2026-03-02 | RPRX | Sale | 10.4K | $47.01 | $490K | SEC ↗ |
| 2026-02-23 | RPRX | Sale | 32.9K | $45.32 | $1.5M | SEC ↗ |
| 2026-02-23 | RPRX | Sale | 1,875 | $45.32 | $85K | SEC ↗ |
| 2026-02-04 | RPRX | Sale | 19.1K | $43.29 | $826K | SEC ↗ |
| 2026-02-04 | RPRX | Sale | 1,087 | $43.29 | $47K | SEC ↗ |
| 2026-02-03 | RPRX | Sale | 108.8K | $42.84 | $4.7M | SEC ↗ |
| 2026-02-03 | RPRX | Sale | 6,195 | $42.84 | $265K | SEC ↗ |
| 2026-02-02 | RPRX | Sale | 5,843 | $42.08 | $246K | SEC ↗ |
| 2026-02-02 | RPRX | Sale | 102.6K | $42.08 | $4.3M | SEC ↗ |
| 2026-01-20 | RPRX | Sale | 65.8K | $39.35 | $2.6M | SEC ↗ |
| 2026-01-20 | RPRX | Sale | 3,750 | $39.35 | $148K | SEC ↗ |
| 2026-01-02 | RPRX | Sale | 3,750 | $38.42 | $144K | SEC ↗ |
| 2026-01-02 | RPRX | Sale | 65.8K | $38.42 | $2.5M | SEC ↗ |
| 2025-12-15 | RPRX | Sale | 65.8K | $38.36 | $2.5M | SEC ↗ |
| 2025-12-15 | RPRX | Sale | 3,750 | $38.36 | $144K | SEC ↗ |
| 2025-12-01 | RPRX | Sale | 65.8K | $39.87 | $2.6M | SEC ↗ |
| 2025-12-01 | RPRX | Sale | 3,750 | $39.87 | $149K | SEC ↗ |
| 2025-11-24 | RPRX | Sale | 3,126 | $38.67 | $121K | SEC ↗ |
| 2025-11-24 | RPRX | Sale | 624 | $37.96 | $24K | SEC ↗ |
| 2025-11-24 | RPRX | Sale | 55.1K | $38.67 | $2.1M | SEC ↗ |
| 2025-11-24 | RPRX | Sale | 10.7K | $37.96 | $406K | SEC ↗ |
| 2025-11-17 | RPRX | Sale | 3,750 | $39.30 | $147K | SEC ↗ |
| 2025-11-17 | RPRX | Sale | 65.8K | $39.30 | $2.6M | SEC ↗ |